{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:34:43Z","timestamp":1762508083039},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00108-020-00789-x","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T14:03:37Z","timestamp":1587737017000},"page":"558-564","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hormontherapie in der Peri- und Postmenopause"],"prefix":"10.1007","volume":"61","author":[{"given":"M.","family":"Henes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"H\u00fcbner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,24]]},"reference":[{"key":"789_CR1","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","volume":"291","author":"GL Anderson","year":"2004","unstructured":"Anderson\u00a0GL, Limacher\u00a0M, Assaf\u00a0AR et\u00a0al (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial. JAMA 291:1701\u20131712","journal-title":"JAMA"},{"key":"789_CR2","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1001\/jama.291.18.2212","volume":"291","author":"E Banks","year":"2004","unstructured":"Banks\u00a0E, Beral\u00a0V, Reeves\u00a0G et\u00a0al (2004) Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women. JAMA 291:2212\u20132220","journal-title":"JAMA"},{"key":"789_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002229.pub4","author":"HM Boardman","year":"2015","unstructured":"Boardman\u00a0HM, Hartley\u00a0L, Eisinga\u00a0A et al (2015) Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD002229.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"789_CR4","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1161\/ATVBAHA.109.196022","volume":"30","author":"M Canonico","year":"2010","unstructured":"Canonico\u00a0M, Fournier\u00a0A, Carcaillon\u00a0L et\u00a0al (2010) Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study. Arterioscler Thromb Vasc Biol 30:340\u2013345","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"789_CR5","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","volume":"115","author":"M Canonico","year":"2007","unstructured":"Canonico\u00a0M, Oger\u00a0E, Plu-Bureau\u00a0G et al (2007) Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation 115:840\u2013845","journal-title":"Circulation"},{"key":"789_CR6","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","volume":"290","author":"JA Cauley","year":"2003","unstructured":"Cauley\u00a0JA, Robbins\u00a0J, Chen\u00a0Z et\u00a0al (2003) Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women\u2019s Health Initiative randomized trial. JAMA 290:1729\u20131738","journal-title":"JAMA"},{"key":"789_CR7","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/S0140-6736(14)61687-1","volume":"385","author":"V Beral","year":"2015","unstructured":"Collaborative Group on Epidemiological Studies of Ovarian C, Beral\u00a0V, Gaitskell\u00a0K et al (2015) Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet 385:1835\u20131842","journal-title":"Lancet"},{"key":"789_CR8","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","volume":"292","author":"M Cushman","year":"2004","unstructured":"Cushman\u00a0M, Kuller\u00a0LH, Prentice\u00a0R et\u00a0al (2004) Estrogen plus progestin and risk of venous thrombosis. JAMA 292:1573\u20131580","journal-title":"JAMA"},{"key":"789_CR9","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1097\/GME.0000000000000227","volume":"21","author":"H Gu","year":"2014","unstructured":"Gu\u00a0H, Zhao\u00a0X, Zhao\u00a0X et al (2014) Risk of stroke in healthy postmenopausal women during and after hormone therapy: a\u00a0meta-analysis. Menopause 21:1204\u20131210","journal-title":"Menopause"},{"key":"789_CR10","volume-title":"Menopause Full Guideline, Methods, evidence and recommendations","author":"Guideline NIFHaCEN","year":"2015","unstructured":"Guideline NIFHaCEN (2015) Menopause Full Guideline, Methods, evidence and recommendations"},{"key":"789_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-138-1-200301070-00005","volume":"138","author":"AM Kanaya","year":"2003","unstructured":"Kanaya\u00a0AM, Herrington\u00a0D, Vittinghoff\u00a0E et al (2003) Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen\/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 138:1\u20139","journal-title":"Ann Intern Med"},{"key":"789_CR12","volume-title":"Prophylaxe, Diagnostik und Therapie der OSTEOPOROSE bei postmenopausalen Frauen und bei M\u00e4nnern","author":"Leitlinienkommision","year":"2017","unstructured":"Leitlinienkommision (2017) Prophylaxe, Diagnostik und Therapie der OSTEOPOROSE bei postmenopausalen Frauen und bei M\u00e4nnern"},{"key":"789_CR13","volume-title":"AWMF Registernummer: 032\/034-OL","author":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft DK, Awmf)","year":"2018","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft DK, Awmf) (2018) Diagnostik, Therapie und Nachsorge der Patientinnen mit Endometriumkarzinom. In: AWMF Registernummer: 032\/034-OL"},{"key":"789_CR14","volume-title":"S3-Leitlinie Diagnostik, Therapie und Nachsorge maligner Ovarialtumoren","author":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft DK, Awmf)","year":"2019","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft DK, Awmf) (2019) S3-Leitlinie Diagnostik, Therapie und Nachsorge maligner Ovarialtumoren"},{"key":"789_CR15","volume-title":"Peri- and Postmenopause \u2013 Diagnosis and Interventions. Guideline of the DGGG, SGGG and OEGGG (S3-Level)","author":"Leitlininenkommission","year":"2020","unstructured":"Leitlininenkommission (2020) Peri- and Postmenopause \u2013 Diagnosis and Interventions. Guideline of the DGGG, SGGG and OEGGG (S3-Level)"},{"key":"789_CR16","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/ijc.26026","volume":"130","author":"KJ Lin","year":"2012","unstructured":"Lin\u00a0KJ, Cheung\u00a0WY, Lai\u00a0JY et al (2012) The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer. Int J Cancer 130:419\u2013430","journal-title":"Int J Cancer"},{"key":"789_CR17","doi-asserted-by":"publisher","first-page":"a386","DOI":"10.1136\/bmj.a386","volume":"337","author":"B Liu","year":"2008","unstructured":"Liu\u00a0B, Beral\u00a0V, Balkwill\u00a0A et\u00a0al (2008) Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study. BMJ 337:a386","journal-title":"BMJ"},{"key":"789_CR18","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1001\/jama.2013.278040","volume":"310","author":"JE Manson","year":"2013","unstructured":"Manson\u00a0JE, Chlebowski\u00a0RT, Stefanick\u00a0ML et\u00a0al (2013) Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women\u2019s Health Initiative randomized trials. JAMA 310:1353\u20131368","journal-title":"JAMA"},{"key":"789_CR19","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00125-004-1448-x","volume":"47","author":"KL Margolis","year":"2004","unstructured":"Margolis\u00a0KL, Bonds\u00a0DE, Rodabough\u00a0RJ et\u00a0al (2004) Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women\u2019s Health Initiative Hormone Trial. Diabetologia 47:1175\u20131187","journal-title":"Diabetologia"},{"key":"789_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s10654-016-0116-z","volume":"31","author":"LS Morch","year":"2016","unstructured":"Morch\u00a0LS, Lidegaard\u00a0O, Keiding\u00a0N et\u00a0al (2016) The influence of hormone therapies on colon and rectal cancer. Eur J Epidemiol 31:481\u2013489","journal-title":"Eur J Epidemiol"},{"key":"789_CR21","first-page":"657","volume":"56","author":"AO Mueck","year":"2015","unstructured":"Mueck\u00a0AO (2015) Anwendungsempfehlungen zur Hormonsubstitution in Klimakterium und Postmenopause. Aktualisierte gemeinsame Empfehlungen. Frauenarzt 56:657\u2013660","journal-title":"Frauenarzt"},{"key":"789_CR22","first-page":"442","volume":"57","author":"AO Mueck","year":"2016","unstructured":"Mueck\u00a0AO (2016) WHI-Autoren mahnen: Millionen von Frauen m\u00fcssen unn\u00f6tig leiden! Frauenarzt 57:442\u2013443","journal-title":"Frauenarzt"},{"key":"789_CR23","volume-title":"Klinische Endokrinologie f\u00fcr Frauen\u00e4rzte","author":"O Ortmann","year":"2009","unstructured":"Ortmann\u00a0O, Hadji\u00a0P (2009) Endokrinologie der perimenopausalen \u00dcbergangsphase, der Postmenopause und des Seniums. In: Leidenberger\u00a0F, Strowitzki\u00a0T, Ortmann\u00a0O (Hrsg) Klinische Endokrinologie f\u00fcr Frauen\u00e4rzte. Springer, Berlin Heidelberg"},{"key":"789_CR24","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1210\/jc.2010-1746","volume":"96","author":"JF Randolph Jr.","year":"2011","unstructured":"Randolph\u00a0JF Jr., Zheng\u00a0H, Sowers\u00a0MR et al (2011) Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J\u00a0Clin Endocrinol Metab 96:746\u2013754","journal-title":"J Clin Endocrinol Metab"},{"key":"789_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw\u00a0JE, Anderson\u00a0GL, Prentice\u00a0RL et\u00a0al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial. JAMA 288:321\u2013333","journal-title":"JAMA"},{"key":"789_CR26","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","volume":"297","author":"JE Rossouw","year":"2007","unstructured":"Rossouw\u00a0JE, Prentice\u00a0RL, Manson\u00a0JE et\u00a0al (2007) Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297:1465\u20131477","journal-title":"JAMA"},{"key":"789_CR27","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.1021\/bi00390a016","volume":"26","author":"CF Semenkovich","year":"1987","unstructured":"Semenkovich\u00a0CF, Ostlund\u00a0RE Jr. (1987) Estrogens induce low-density lipoprotein receptor activity and decrease intracellular cholesterol in human hepatoma cell line Hep G2. Biochemistry 26:4987\u20134992","journal-title":"Biochemistry"},{"key":"789_CR28","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.ejca.2014.03.006","volume":"50","author":"SH Shim","year":"2014","unstructured":"Shim\u00a0SH, Lee\u00a0SJ, Kim\u00a0SN (2014) Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors: a\u00a0meta-analysis. Eur J Cancer 50:1628\u20131637","journal-title":"Eur J Cancer"},{"key":"789_CR29","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1161\/01.CIR.0000032261.12632.D7","volume":"106","author":"A Wakatsuki","year":"2002","unstructured":"Wakatsuki\u00a0A, Okatani\u00a0Y, Ikenoue\u00a0N et al (2002) Different effects of oral conjugated equine estrogen and transdermal estrogen replacement therapy on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women. Circulation 106:1771\u20131776","journal-title":"Circulation"},{"key":"789_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s10304-019-00297-8","volume":"18","author":"E Windler","year":"2020","unstructured":"Windler\u00a0E, Hadji\u00a0P, Ortmann\u00a0O (2020) Hormonersatztherapie und Pr\u00e4vention gem\u00e4\u00df S3-Leitlinie. Gyn\u00e4kol Endokrinol 18:14\u201320","journal-title":"Gyn\u00e4kol Endokrinol"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-020-00789-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-020-00789-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-020-00789-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T04:50:49Z","timestamp":1619326249000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-020-00789-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["789"],"URL":"https:\/\/doi.org\/10.1007\/s00108-020-00789-x","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,24]]},"assertion":[{"value":"24 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Henes und S.\u00a0H\u00fcbner geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autorinnen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}